Overactive bladder drug not linked to CV events
Patients with overactive bladder taking this OAB drug did not experience an excess risk of CV events compared with other treatments.
FDA approves first sensor-enabled inhaler
Asthma patients may soon treat themselves with first-ever digital maintenance inhaler.
2 Commerce Drive Cranbury, NJ 08512